- Home
- SSKN vs TLPH Comparison
SSKN vs TLPH Comparison
Compare SSKN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- TLPH
- Stock Information
- Founded
- SSKN 1989
- TLPH 2005
- Country
- SSKN United States
- TLPH United States
- Employees
- SSKN N/A
- TLPH N/A
- Industry
- SSKN Medical/Dental Instruments
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- TLPH Health Care
- Exchange
- SSKN Nasdaq
- TLPH Nasdaq
- Market Cap
- SSKN 9.7M
- TLPH 10.6M
- IPO Year
- SSKN 2005
- TLPH 2011
- Fundamental
- Price
- SSKN $2.37
- TLPH $0.46
- Analyst Decision
- SSKN Strong Buy
- TLPH Strong Buy
- Analyst Count
- SSKN 1
- TLPH 1
- Target Price
- SSKN $6.00
- TLPH $6.00
- AVG Volume (30 Days)
- SSKN 13.7K
- TLPH 42.9K
- Earning Date
- SSKN 08-13-2025
- TLPH 08-13-2025
- Dividend Yield
- SSKN N/A
- TLPH N/A
- EPS Growth
- SSKN N/A
- TLPH N/A
- EPS
- SSKN N/A
- TLPH N/A
- Revenue
- SSKN $33,620,000.00
- TLPH $27,000.00
- Revenue This Year
- SSKN $3.31
- TLPH N/A
- Revenue Next Year
- SSKN $9.67
- TLPH $14,533.26
- P/E Ratio
- SSKN N/A
- TLPH N/A
- Revenue Growth
- SSKN 3.30
- TLPH N/A
- 52 Week Low
- SSKN $2.10
- TLPH $0.43
- 52 Week High
- SSKN $3.80
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- SSKN 50.57
- TLPH 43.60
- Support Level
- SSKN $2.26
- TLPH $0.45
- Resistance Level
- SSKN $2.89
- TLPH $0.48
- Average True Range (ATR)
- SSKN 0.19
- TLPH 0.03
- MACD
- SSKN 0.02
- TLPH -0.00
- Stochastic Oscillator
- SSKN 28.99
- TLPH 28.33
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.